Please use this identifier to cite or link to this item:
|Appears in Collections:||Faculty of Health Sciences and Sport Journal Articles|
|Peer Review Status:||Unrefereed|
|Title:||PRECIS-2 helps researchers design more applicable RCTs while CONSORT Extension for Pragmatic Trials helps knowledge users decide whether to apply them|
|Citation:||Zwarenstein M, Treweek S & Loudon K (2017) PRECIS-2 helps researchers design more applicable RCTs while CONSORT Extension for Pragmatic Trials helps knowledge users decide whether to apply them. Commentary on: O.M. Dekkers, P.M. Bossuytd, J.P. Vandenbroucke, How trial results are intended to be used: is PRECIS-2 a step forward? J Clin Epidemiol, 84 (2017), pp. 25–26. M.G. Zuidgeest, I. Goetz, D.E. Grobbee, PRECIS-2 in perspective: what's next for pragmatic trials? J Clin Epidemiol, 84 (2017), pp. 22–24. D.L. Riddle, Consequences of randomized clinical trial design decisions need to be clarified. J Clin Epidemiol, 77 (2016), pp. 13–14.. Journal of Clinical Epidemiology, 84, pp. 27-29. https://doi.org/10.1016/j.jclinepi.2016.10.010|
|Abstract:||First paragraph: We appreciate the efforts of the editors of the Journal of Clinical Epidemiology to provide a forum for discussion of pragmatismi in randomized trials (RCTs), with many items in recent years, including three in this issue by Dekkers et al ii, Zuidegeest et al. iii and Riddle iv. We are encouraged that these three authors agree on the importance of pragmatism and the relevance of PRECIS-2 to RCT designv, our tool to promote better matching of the choices made during design with the intended use of that trial’s results. We thank them for their insightful comments relating to the varied meanings of generalizability, and the relationship between pragmatic and explanatory characteristics and internal validity and applicability (which we use as a synonym for generalizability) of trial results, to which we respond below.|
|Rights:||This item has been embargoed for a period. During the embargo please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study. Accepted refereed manuscript of: Zwarenstein M, Treweek S & Loudon K (2017) PRECIS-2 helps researchers design more applicable RCTs while CONSORT Extension for Pragmatic Trials helps knowledge users decide whether to apply them. Journal of Clinical Epidemiology, 84, pp. 27-29. DOI: 10.1016/j.jclinepi.2016.10.010 © 2017, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/|
Files in This Item:
|JCE Commentary 2016.pdf||Fulltext - Accepted Version||410.9 kB||Adobe PDF||View/Open|
This item is protected by original copyright
A file in this item is licensed under a Creative Commons License
Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/
If you believe that any material held in STORRE infringes copyright, please contact email@example.com providing details and we will remove the Work from public display in STORRE and investigate your claim.